Funding for this research was provided by:
Earlier.org, Friends for an Earlier Breast Cancer Test (EORG 170099-01)
Laura Crandall Brown Foundation and The Foundation for Women’s Cancer (N/A)
National Institutes of Health (P41 EB020594)
Weill Cornell Medicine funding through distribution of royalties from intellectual property generated by the Barany laboratory (N/A)
Received: 23 September 2019
Accepted: 23 January 2020
First Online: 31 January 2020
Ethics approval and consent to participate
: The study did not involve human participation and is not subjected to ethical approval and consent.
: The study did not involve human participation and is not subjected to consent for publication.
: MDB, AHM, JH, PBF, SFG and FB are shareholders in AcuamarkDx.